Replies to post #595500 on NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Yes hankmanhub. Any BP could easily buy Oncovir but unlike NWBO, it cannot extend the Poly ICLC patent and thus will face competition from all the other companies that are capable to manufacture Poly ICLC.

Only NWBO can extend that patent as an integral part of its DCVax-L vaccine.